scispace - formally typeset
Search or ask a question
Posted Content•DOI•

A core transcriptional signature of human microglia: derivation and utility in describing region-dependent alterations associated with Alzheimer\'s disease

Anirudh Patir1, Barbara Shih1, Barry W. McColl1, Tom C. Freeman1•
University of Edinburgh1
26 Apr 2018-bioRxiv (Cold Spring Harbor Laboratory)-pp 308908
TL;DR: A core transcriptional signature of human microglia with 249 genes was derived and found conserved across brain regions, encompassing the CNS, and the utility of this signature was demonstrated by its use in detecting qualitative and quantitative region-specific alterations in aging and Alzheimer's disease.
Abstract: Growing recognition of the pivotal role microglia play in neurodegenerative and neuroinflammatory disorders has accentuated the need to better characterize their function in health and disease. Studies in mouse, have applied transcriptome-wide profiling of microglia to reveal key features of microglial ontogeny, functional profile and phenotypic diversity. Whilst similar in many ways, human microglia exhibit clear differences to their mouse counterparts, underlining the need to develop a better understanding of the human microglial profile. On examining published microglia gene signatures, little consistency was observed between studies. Hence, we set out to define a conserved microglia signature of the human central nervous system (CNS), through a comprehensive meta-analysis of existing transcriptomic resources. Nine datasets derived from cells and tissue, isolated from different regions of the CNS across numerous donors, were subjected independently to an unbiased correlation network analysis. From each dataset, a list of coexpressing genes corresponding to microglia was identified. Comparison of individual microglia clusters showed 249 genes highly conserved between them. This core gene signature included all known markers and improves upon published microglial signatures. The utility of this signature was demonstrated by its use in detecting qualitative and quantitative region-specific alterations in aging and Alzheimer’s disease. These analyses highlighted the reactive response of microglia in vulnerable brain regions such as the entorhinal cortex and hippocampus, additionally implicating pathways associated with disease progression. We believe this resource and the analyses described here, will support further investigations in the contribution of human microglia towards the CNS in health and disease. Table of Contents Main points Published microglial transcriptional signatures in mouse and human show poor consensus. A core transcriptional signature of human microglia with 249 genes was derived and found conserved across brain regions, encompassing the CNS. The signature revealed region-dependent microglial alterations in Alzheimer’s, highlighting susceptible CNS regions and the involvement of TYROBP signaling.

Summary (3 min read)

Jump to: [Introduction] – [Comparison of published microglial signatures] – [Transcriptomics data acquisition and pre-processing] – [Gene annotation through coexpression networks analysis] – [Validation of the core human microglial signature] – [Heterogeneity of existing microglial signatures from human and mouse] – [Derivation of a conserved core human microglial signature] – [Validation and description of the core human microglial signature] and [Discussion]

Introduction

  • Microglia are the most abundant myeloid cell type in the central nervous system (CNS), accounting for approximately 5-20% of the brain parenchyma depending on region (Lawson, Perry, Dri, & Gordon, 1990; Mittelbronn, Dietz, Schluesener, & Meyermann, 2001) .
  • These cells are phenotypically plastic and exhibit a wide spectrum of activity influenced by local and systemic factors (Cunningham, 2013; Perry & Holmes, 2014) .
  • As the primary immune sentinels of the CNS, microglia migrate towards lesions and sites of infection, where they attain an activated state that reflects their inflammatory environment (Leong & Ling, 1992) .
  • Recent transcriptomic studies have sought to characterize the human microglial transcriptomic signature from the CNS of non-neuropathologic individuals using data derived from either cells or tissue isolated from different brain regions (Darmanis et al., 2015; Galatro et al., 2017; Hawrylycz et al., 2012; Oldham et al., 2008) .

Comparison of published microglial signatures

  • Ten publications that defined microglial signatures, four in human and six in mouse, were identified (Table 1 ).
  • To compare across studies, genes from each signature were converted to a common identifier i.e. HGNC (Povey et al., 2001) or MGI (Shaw, 2009) for human and mouse, respectively, using the online tool g:Profiler (Reimand et al., 2016) .
  • CC-BY-NC-ND 4.0 International license a certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
  • The copyright holder for this preprint (which was not this version posted April 26, 2018.

Transcriptomics data acquisition and pre-processing

  • Tissue and cell transcriptomic datasets derived from the CNS were acquired for the derivation of the human microglial signature.
  • The ABA data, generated on the Agilent microarray platform, consisted of 3,702 tissue samples taken from six individuals with up to 411 unique anatomical regions of the brain.
  • Data quality was assessed using the ArrayQualityMetrics package (Kauffmann, Gentleman, & Huber, 2008) in Bioconductor, and samples failing more than one of three metrics (between arrays comparison, array intensity distribution and variance mean difference) were removed.
  • GTEX and ABA preprocessed RNA-Seq data was downloaded directly from the GTEx portal .
  • CC-BY-NC-ND 4.0 International license a certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.

Gene annotation through coexpression networks analysis

  • To define a core microglial gene signature, the tissue and cell transcriptomics datasets described above were analyzed using the coexpression network analysis tool Graphia Professional.
  • For each dataset, Pearson correlations (r) were calculated between all genes to produce a gene-to-gene correlation matrix.
  • From this matrix, a gene coexpression network (GCN) was generated, where nodes represented genes and genes correlating greater than a defined threshold were connected by edges.
  • All Pearson threshold values used for individual datasets were above r ≥ 0.7 and thereby graphs included only correlations that were highly unlikely to occur by chance .
  • For each dataset, the threshold for correlations was further adjusted to achieve a single microglial cluster containing the three canonical marker genes for microglia, CX3CR1, AIF1 and CSF1R (Elmore et al., 2014; Mittelbronn et al., 2001) .

Validation of the core human microglial signature

  • Various lines of evidence were investigated to validate the conserved nature of the derived human microglial signature.
  • The copyright holder for this preprint (which was not this version posted April 26, 2018.
  • BioRxiv preprint mouse, for comparable regions (Lawson et al., 1990), also known as doi.
  • Signature genes were then compared with other published mouse and human microglial signatures.
  • A GCN constructed (r ≥ 0.7) from the GTEx RNA-Seq dataset revealed five gene clusters enriched in Galatro et al. signature genes, representing various region-specific expression profiles (Table S5 ).

Heterogeneity of existing microglial signatures from human and mouse

  • To examine the human microglia gene signature, previous signatures from human brain tissue or cells were compared .
  • Four such studies varied considerably in the number of genes they defined, ranging from 21 to 1,236 genes.
  • Of the 1,464 unique genes identified in all these studies, only a fraction (15%, 214 genes) were present in two or more signatures, with only 10 genes reported by all four publications.
  • To verify that these results were not purely attributed by the individual variation in humans, the six publications reporting mouse-microglial signatures were also compared.
  • Altogether these listed 690 genes (ranging from 47 to 433 genes) with 300 orthologues common to studies in human.

Derivation of a conserved core human microglial signature

  • Observing the variability across published studies, the authors set out to define a human microglia gene signature from human tissue and cell data using a GCN . CC-BY-NC-ND 4.0 International license a certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
  • This method exploits the inherent variability amongst samples due to variation in sampling, donors and cellular diversity across different CNS regions.
  • For constructing GCNs, genes are represented by nodes, and connected by an edge based on the similarity between their expression profiles, as quantified by the Pearson correlation coefficient .
  • The final high confidence microglia gene signature was defined by 249 genes, which were present in three or more dataset-derived clusters, so as to avoid biases towards individual datasets.

Validation and description of the core human microglial signature

  • To validate the microglial signature genes, various lines of evidence were examined.
  • CC-BY-NC-ND 4.0 International license a certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
  • The copyright holder for this preprint (which was not this version posted April 26, 2018.
  • A majority of the core signature genes (64%, 142 genes) were identified in two or more human studies, whilst 99 genes overlapped solely with the Galatro et al. signature.
  • To further validate the specificity of the current microglial signature, the coexpression of these genes was compared with that of the Galatro et al. signature (1,236 genes), which included the majority of genes in other signatures.

Discussion

  • CC-BY-NC-ND 4.0 International license a certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
  • The copyright holder for this preprint (which was not this version posted April 26, 2018.
  • The authors initial investigations demonstrated that published microglia gene signatures vary considerably in their size and composition relative to one another.
  • When comparing Alzheimer's to age-matched controls, a similar trend towards increased expression levels of signature genes was also observed.

Did you find this useful? Give us your feedback

Figures (1)

Content maybe subject to copyright    Report

A core transcriptional signature of human microglia: derivation and 1
utility in describing region-dependent alterations associated with 2
Alzheimer’s disease 3
Anirudh Patir
1
, Barbara Shih
1
, Barry W. McColl
1,2
and Tom C. Freeman
1†
4
5
1. The Roslin Institute, University of Edinburgh, Easter Bush, Midlothian, 6
Scotland, UK EH25 9RG. 7
2. UK Dementia Research Institute at The University of Edinburgh, Edinburgh 8
Medical School, The Chancellor's Building, 49 Little France Crescent, 9
Edinburgh, EH16 4TJ, UKUK. 10
11
†
Corresponding author 12
13
Running title: A functional profile of human microglia. 14
15
Acknowledgments 16
T.C.F. and B.W.M. are funded by an Institute Strategic Programme Grant funding 17
from the Biotechnology and Biological Sciences Research Council [BB/J004227/1]. 18
B.W.M. receives funding from the UK Dementia Research Institute and Medical 19
Research Council [MR/L003384/1]. B.S. is supported by Experimental Medicine 20
Challenge Grant funding from the Medical Research Council [MR/M003833/1]. 21
22
Conflict of Interest Statement 23
The authors have no competing financial interests. 24
25
Word Count: 5781 26
27
.CC-BY-NC-ND 4.0 International licensea
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
The copyright holder for this preprint (which was notthis version posted April 26, 2018. ; https://doi.org/10.1101/308908doi: bioRxiv preprint
Abstract 28
Growing recognition of the pivotal role microglia play in neurodegenerative and 29
neuroinflammatory disorders has accentuated the need to better characterize their 30
function in health and disease. Studies in mouse, have applied transcriptome-wide 31
profiling of microglia to reveal key features of microglial ontogeny, functional profile 32
and phenotypic diversity. Whilst similar in many ways, human microglia exhibit clear 33
differences to their mouse counterparts, underlining the need to develop a better 34
understanding of the human microglial profile. On examining published microglia 35
gene signatures, little consistency was observed between studies. Hence, we set out 36
to define a conserved microglia signature of the human central nervous system 37
(CNS), through a comprehensive meta-analysis of existing transcriptomic resources. 38
Nine datasets derived from cells and tissue, isolated from different regions of the 39
CNS across numerous donors, were subjected independently to an unbiased 40
correlation network analysis. From each dataset, a list of coexpressing genes 41
corresponding to microglia was identified. Comparison of individual microglia clusters 42
showed 249 genes highly conserved between them. This core gene signature 43
included all known markers and improves upon published microglial signatures. The 44
utility of this signature was demonstrated by its use in detecting qualitative and 45
quantitative region-specific alterations in aging and Alzheimer’s disease. These 46
analyses highlighted the reactive response of microglia in vulnerable brain regions 47
such as the entorhinal cortex and hippocampus, additionally implicating pathways 48
associated with disease progression. We believe this resource and the analyses 49
described here, will support further investigations in the contribution of human 50
microglia towards the CNS in health and disease. 51
52
53
54
55
56
57
58
.CC-BY-NC-ND 4.0 International licensea
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
The copyright holder for this preprint (which was notthis version posted April 26, 2018. ; https://doi.org/10.1101/308908doi: bioRxiv preprint
Keywords 59
Microglia, transcriptome, neurodegenerative disease, aging, Alzheimer’s. 60
Table of Contents: Main points 61
• Published microglial transcriptional signatures in mouse and human show 62
poor consensus. 63
• A core transcriptional signature of human microglia with 249 genes was 64
derived and found conserved across brain regions, encompassing the CNS. 65
• The signature revealed region-dependent microglial alterations in Alzheimer’s, 66
highlighting susceptible CNS regions and the involvement of TYROBP 67
signaling. 68
69
.CC-BY-NC-ND 4.0 International licensea
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
The copyright holder for this preprint (which was notthis version posted April 26, 2018. ; https://doi.org/10.1101/308908doi: bioRxiv preprint
Introduction 70
Microglia are the most abundant myeloid cell type in the central nervous system 71
(CNS), accounting for approximately 5-20% of the brain parenchyma depending on 72
region (Lawson, Perry, Dri, & Gordon, 1990; Mittelbronn, Dietz, Schluesener, & 73
Meyermann, 2001). These cells are phenotypically plastic and exhibit a wide 74
spectrum of activity influenced by local and systemic factors (Cunningham, 2013; 75
Perry & Holmes, 2014). Through development into adulthood, microglia influence the 76
proliferation and differentiation of surrounding cells while regulating processes such 77
as myelination, synaptic organization and synaptic signaling (Colonna & Butovsky, 78
2017; Hoshiko, Arnoux, Avignone, Yamamoto, & Audinat, 2012; Paolicelli et al., 79
2011; Prinz & Priller, 2014). As the primary immune sentinels of the CNS, microglia 80
migrate towards lesions and sites of infection, where they attain an activated state 81
that reflects their inflammatory environment (Leong & Ling, 1992). In these states, 82
they can support tissue remodeling and phagocytose cellular debris, toxic protein 83
aggregates and microbes (Colonna & Butovsky, 2017; Li & Barres, 2017). During 84
neuroinflammation these cells coordinate an immune response by releasing 85
cytokines, chemoattractants and presenting antigens, thereby communicating with 86
other immune cells locally and recruited from the circulation (Hanisch & Kettenmann, 87
2007; Hickey & Kimura, 1988; Scholz & Woolf, 2007). 88
In common with mononuclear phagocyte populations throughout the body, recent 89
studies have begun to reveal the diversity of microglial phenotypes in health, aging 90
and disease states, as well as their unique molecular identity in relation to other CNS 91
resident cells and non-parenchymal macrophages (Durafourt et al., 2012; Hanisch, 92
2013; Li & Barres, 2017; McCarthy; Salter & Stevens, 2017). The application of 93
transcriptomic methods has been integral to these advances by enabling an 94
unbiased and panoramic perspective of the functional profile of microglia. In addition 95
to an improved understanding of the variety of context-dependent microglial 96
phenotypes, other key benefits have arisen from these studies, notably the 97
development of new tools to label, isolate and manipulate microglia (Bennett et al., 98
2016; Butovsky et al., 2014; Hickman et al., 2013; Satoh et al., 2016). Although most 99
studies have been conducted in mice, a considerable body of data is now emerging 100
from human post-mortem and biopsy tissue (Darmanis et al., 2015; Galatro et al., 101
2017; Gosselin et al., 2017; Olah et al., 2018; Y. Zhang et al., 2016). Whilst there are 102
.CC-BY-NC-ND 4.0 International licensea
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
The copyright holder for this preprint (which was notthis version posted April 26, 2018. ; https://doi.org/10.1101/308908doi: bioRxiv preprint
many conserved features between rodent and human microglia, the importance of 103
further refining our understanding specifically of human microglia is underscored by 104
important differences that have been observed between them (Butovsky et al., 2014; 105
Galatro et al., 2017; Miller, Horvath, & Geschwind, 2010). 106
Recent transcriptomic studies have sought to characterize the human microglial 107
transcriptomic signature from the CNS of non-neuropathologic individuals using data 108
derived from either cells or tissue isolated from different brain regions (Darmanis et 109
al., 2015; Galatro et al., 2017; Hawrylycz et al., 2012; Oldham et al., 2008). These 110
analyses have been crucial in expanding our knowledge of their functional biology, 111
however, our preliminary analyses found there to be little inter-study agreement 112
across the published microglia gene signatures. Such inconsistency may have arisen 113
due to technical differences in tissue sampling, brain areas analyzed, differences in 114
patient characteristics and biological variance including the heterogeneity of different 115
microglia populations (Grabert et al., 2016; Lai, Dhami, Dibal, & Todd, 2011; Lawson 116
et al., 1990; Vincenti et al., 2016; Yokokura et al., 2011). This highlighted a need to 117
derive a refined human microglial signature that would enable a more precise 118
characterization of these cells in the healthy and diseased human brain. We 119
therefore set out to define the core transcriptional signature of human microglia, i.e. 120
shared by all microglial populations of the human CNS. To achieve this, we have 121
performed an extensive meta-analysis of nine human cell and tissue transcriptomics 122
datasets derived from numerous brain regions and donors. Secondly, we have used 123
this signature to investigate region-dependent changes, while highlighting the 124
influence of microglial numbers and activation in human tissue transcriptomics for 125
Alzheimer’s and aging. 126
Methods 127
Comparison of published microglial signatures 128
Ten publications that defined microglial signatures, four in human and six in mouse, 129
were identified (Table 1). To compare across studies, genes from each signature 130
were converted to a common identifier i.e. HGNC (Povey et al., 2001) or MGI (Shaw, 131
2009) for human and mouse, respectively, using the online tool g:Profiler (Reimand 132
et al., 2016). Subsequently, the tool was also used for interspecies comparison 133
based on the MGI homology database, identifying human orthologues of mouse 134
.CC-BY-NC-ND 4.0 International licensea
certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under
The copyright holder for this preprint (which was notthis version posted April 26, 2018. ; https://doi.org/10.1101/308908doi: bioRxiv preprint
Citations
More filters
Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. - eScholarship

[...]

Jessica A. Hamerman, Nadia K. Tchao, Clifford A. Lowell, Lewis L. Lanier
01 Jun 2005
TL;DR: This article examined the responses of mice lacking DAP12 to stimulation through Toll-like receptors (TLRs) and found that one or more DAP-pairing receptors negatively regulate signaling through TLRs.
Abstract: DAP12 is a signaling adaptor containing an immunoreceptor tyrosine-based activation motif (ITAM) that pairs with receptors on myeloid cells and natural killer cells. We examine here the responses of mice lacking DAP12 to stimulation through Toll-like receptors (TLRs). Unexpectedly, DAP12-deficient macrophages produced higher concentrations of inflammatory cytokines in response to a variety of pathogenic stimuli. Additionally, macrophages deficient in spleen tyrosine kinase (Syk), which signals downstream of DAP12, showed a phenotype identical to that of DAP12-deficient macrophages. DAP12-deficient mice were more susceptible to endotoxic shock and had enhanced resistance to infection by the intracellular bacterium Listeria monocytogenes. These data suggest that one or more DAP12-pairing receptors negatively regulate signaling through TLRs.

29 citations

References
More filters
Journal Article•DOI•
Evaluation of age-related changes in translocator protein (TSPO) in human brain using 11C-[R]-PK11195 PET

[...]

Ajay Kumar1, Otto Muzik1, Varun Shandal1, Diane C. Chugani, Pulak K. Chakraborty1, Harry T. Chugani1 •
Wayne State University1
04 Oct 2012-Journal of Neuroinflammation
TL;DR: In this paper, the distribution and expression of translocator protein in the human brain using 11C-[R]-PK-11195 positron emission tomography (PK11195 PET) and evaluated agerelated changes.
Abstract: We studied the distribution and expression of translocator protein in the human brain using 11C-[R]-PK-11195 positron emission tomography (PK11195 PET) and evaluated age-related changes. A dynamic PK11195 PET scan was performed in 15 normal healthy adults (mean age: 29 ±8.5 years (range: 20 to 49); 7 males) and 10 children (mean age: 8.8 ±5.2 years (range: 1.2 to 17); 5 males), who were studied for potential neuroinflammation but showed no focally increased PK11195 binding. The PET images were evaluated by calculating standard uptake values and regional binding potential, based on a simplified reference region model, as well as with a voxel-wise analysis using statistical parametric mapping. PK11195 uptake in the brain is relatively low, compared with the subcortical structures, and symmetrical. The overall pattern of PK11195 distribution in the brain does not change with age. PK11195 uptake was lowest in the frontal-parietal-temporal cortex and highest in the pituitary gland, midbrain, thalamus, basal ganglia, occipital cortex, hippocampus and cerebellum, in descending order. White matter showed negligible PK11195 uptake. Overall, brain PK11195 uptake increased with age, with midbrain and thalamus showing relatively higher increases with age compared with other brain regions. The brain shows low PK11195 uptake, which is lower in the cortex and cerebellum compared with subcortical structures, suggesting a low level of translocator protein expression. There is no hemispheric asymmetry in PK11195 uptake and the overall pattern of PK11195 distribution in the brain does not change with age. However, brain PK11195 uptake increases with age, with the thalamus and midbrain showing relatively higher increases compared with other brain regions. This increase in uptake suggests an age-related increase in translocator protein expression or the number of cells expressing these receptors or both.

82 citations

Journal Article•DOI•
Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.

[...]

Jean-Vianney Haure-Mirande1, Mickael Audrain1, Tomas Fanutza1, Soong Ho Kim1, William L. Klein2, Charles G. Glabe3, Ben Readhead1, Joel T. Dudley1, Robert D. Blitzer1, Minghui Wang1, Bin Zhang1, Eric E. Schadt1, Sam Gandy1, Michelle E. Ehrlich1 •
Icahn School of Medicine at Mount Sinai1, Northwestern University2, University of California, Irvine3
13 Jun 2017-Acta Neuropathologica
TL;DR: Reduction of TYROBP gene expression and/or protein levels could represent an immune-inflammatory therapeutic opportunity for modulating early stage LOAD, potentially leading to slowing or arresting the progression to full-blown clinical and pathological LOAD.
Abstract: Conventional genetic approaches and computational strategies have converged on immune-inflammatory pathways as key events in the pathogenesis of late onset sporadic Alzheimer's disease (LOAD). Mutations and/or differential expression of microglial specific receptors such as TREM2, CD33, and CR3 have been associated with strong increased risk for developing Alzheimer's disease (AD). DAP12 (DNAX-activating protein 12)/TYROBP, a molecule localized to microglia, is a direct partner/adapter for TREM2, CD33, and CR3. We and others have previously shown that TYROBP expression is increased in AD patients and in mouse models. Moreover, missense mutations in the coding region of TYROBP have recently been identified in some AD patients. These lines of evidence, along with computational analysis of LOAD brain gene expression, point to DAP12/TYROBP as a potential hub or driver protein in the pathogenesis of AD. Using a comprehensive panel of biochemical, physiological, behavioral, and transcriptomic assays, we evaluated in a mouse model the role of TYROBP in early stage AD. We crossed an Alzheimer's model mutant APP KM670/671NL /PSEN1 Δexon9 (APP/PSEN1) mouse model with Tyrobp -/- mice to generate AD model mice deficient or null for TYROBP (APP/PSEN1; Tyrobp +/- or APP/PSEN1; Tyrobp -/-). While we observed relatively minor effects of TYROBP deficiency on steady-state levels of amyloid-β peptides, there was an effect of Tyrobp deficiency on the morphology of amyloid deposits resembling that reported by others for Trem2 -/- mice. We identified modulatory effects of TYROBP deficiency on the level of phosphorylation of TAU that was accompanied by a reduction in the severity of neuritic dystrophy. TYROBP deficiency also altered the expression of several AD related genes, including Cd33. Electrophysiological abnormalities and learning behavior deficits associated with APP/PSEN1 transgenes were greatly attenuated on a Tyrobp-null background. Some modulatory effects of TYROBP on Alzheimer's-related genes were only apparent on a background of mice with cerebral amyloidosis due to overexpression of mutant APP/PSEN1. These results suggest that reduction of TYROBP gene expression and/or protein levels could represent an immune-inflammatory therapeutic opportunity for modulating early stage LOAD, potentially leading to slowing or arresting the progression to full-blown clinical and pathological LOAD.

82 citations

"A core transcriptional signature of..." refers background in this paper

  • ...…these findings TYROBP knockout mice models have proven to suppress inflammation in neurodegenerative models including Alzheimer’s, thereby minimizing neuronal dystrophy, implicating a failure in the resolution of inflammation in Alzheimer’s (Bakker et al., 2000; Haure-Mirande et al., 2017)....

    [...]

Journal Article•DOI•
TYROBP in Alzheimer's disease.

[...]

Jing Ma1, Teng Jiang2, Lan Tan2, Lan Tan1, Jin-Tai Yu1, Jin-Tai Yu2 •
Qingdao University1, Nanjing Medical University2
01 Apr 2015-Molecular Neurobiology
TL;DR: The structure, localization, and function of TYROBP are introduced and the possible roles of the protein and its related receptors in Alzheimer’s disease pathogenesis are speculated.
Abstract: Recently, studies have provided convincing data that TYRO protein tyrosine kinase-binding protein (TYROBP), a key regulator in immune systems, is significantly upregulated in the brain of patients with Alzheimer's disease (AD). TYROBP acts as a signaling adaptor protein for numerous cell surface receptors, playing important roles in signal transduction in dendritic cells, osteoclasts, macrophages, and microglia. Although several TYROBP-related cell surface receptors including triggering receptor expressed on myeloid 2 (TREM2), signal regulatory protein β1 (SIRPβ1), and complement receptor 3 (CR3) were found to participate in the pathogenesis of AD, the role of TYROBP in AD still remains elusive. Emerging piece of evidence has demonstrated that TYROBP could enhance phagocytic activity of microglia, which is responsible for the clearance of amyloid-β (Aβ) peptides and apoptotic neurons. TYROBP also participates in suppression of inflammatory responses by repression of microglia-mediated cytokine production and secretion. In this article, we introduce the structure, localization, and function of TYROBP. Meanwhile, we review recent articles concerning the association of TYROBP and its related receptors with AD pathogenesis and speculate the possible roles of TYROBP in this disease. Based on the potential protective actions of TYROBP in AD pathogenesis, targeting TYROBP might provide new opportunities for AD treatment.

81 citations

"A core transcriptional signature of..." refers background in this paper

  • ...Genes relating to TYROBP signaling, which is implicated in Alzheimer’s and together regulates phagocytosis, cell proliferation, activation and survival were significantly upregulated (Keren-Shaul et al.; Landreth & Reed-Geaghan, 2009; Ma et al., 2015)....

    [...]

Journal Article•DOI•
Analyzing the genes related to Alzheimer’s disease via a network and pathway-based approach

[...]

Yanshi Hu1, Juncai Xin1, Ying Hu1, Lei Zhang2, Ju Wang1 •
Tianjin Medical University1, Tianjin University2
27 Apr 2017-Alzheimer's Research & Therapy
TL;DR: The network features of these AD-related genes were analyzed in the context of human interactome and an AD-specific network was inferred using the Steiner minimal tree algorithm, and novel genes potentially associated with AD were identified.
Abstract: Our understanding of the molecular mechanisms underlying Alzheimer’s disease (AD) remains incomplete. Previous studies have revealed that genetic factors provide a significant contribution to the pathogenesis and development of AD. In the past years, numerous genes implicated in this disease have been identified via genetic association studies on candidate genes or at the genome-wide level. However, in many cases, the roles of these genes and their interactions in AD are still unclear. A comprehensive and systematic analysis focusing on the biological function and interactions of these genes in the context of AD will therefore provide valuable insights to understand the molecular features of the disease. In this study, we collected genes potentially associated with AD by screening publications on genetic association studies deposited in PubMed. The major biological themes linked with these genes were then revealed by function and biochemical pathway enrichment analysis, and the relation between the pathways was explored by pathway crosstalk analysis. Furthermore, the network features of these AD-related genes were analyzed in the context of human interactome and an AD-specific network was inferred using the Steiner minimal tree algorithm. We compiled 430 human genes reported to be associated with AD from 823 publications. Biological theme analysis indicated that the biological processes and biochemical pathways related to neurodevelopment, metabolism, cell growth and/or survival, and immunology were enriched in these genes. Pathway crosstalk analysis then revealed that the significantly enriched pathways could be grouped into three interlinked modules—neuronal and metabolic module, cell growth/survival and neuroendocrine pathway module, and immune response-related module—indicating an AD-specific immune-endocrine-neuronal regulatory network. Furthermore, an AD-specific protein network was inferred and novel genes potentially associated with AD were identified. By means of network and pathway-based methodology, we explored the pathogenetic mechanism underlying AD at a systems biology level. Results from our work could provide valuable clues for understanding the molecular mechanism underlying AD. In addition, the framework proposed in this study could be used to investigate the pathological molecular network and genes relevant to other complex diseases or phenotypes.

80 citations

"A core transcriptional signature of..." refers background in this paper

  • ...Alternatively, whilst tissue gene expression can be influenced 414 by cell activation and cell numbers, certain genes found differentially upregulated in 415 both Alzheimer’s and aging, such as TSPO, MS4A6A and MHC class 2 genes, are 416 known contributors of microglial activation based on previous studies (Bergen, 417 Kaing, Jacoline, Gorgels, & Janssen, 2015; Hamelin et al., 2016; Hu et al., 2017)....

    [...]

  • ...…numbers, certain genes found differentially upregulated in both Alzheimer’s and aging, such as TSPO, MS4A6A and MHC class 2 genes, are known contributors of microglial activation based on previous studies (Bergen, Kaing, Jacoline, Gorgels, & Janssen, 2015; Hamelin et al., 2016; Hu et al., 2017)....

    [...]

Journal Article•DOI•
Ligand engagement of Toll-like receptors regulates their expression in cortical microglia and astrocytes

[...]

Carla Marinelli1, Rosa Di Liddo1, Laura Facci1, Thomas Bertalot1, Maria Teresa Conconi1, Morena Zusso1, Stephen D. Skaper1, Pietro Giusti1 •
University of Padua1
30 Dec 2015-Journal of Neuroinflammation
TL;DR: The finding that both homologous and heterologous TLR ligands are capable of regulating TLR2 gene expression, in particular, may have important implications in understanding the relative contributions of different TLRs in neurological disorders associated with neuroinflammation.
Abstract: Background Toll-like receptor (TLR) activation on microglia and astrocytes are key elements in neuroinflammation which accompanies a number of neurological disorders. While TLR activation on glia is well-established to up-regulate pro-inflammatory mediator expression, much less is known about how ligand engagement of one TLR may affect expression of other TLRs on microglia and astrocytes.

75 citations

"A core transcriptional signature of..." refers background in this paper

  • ...These include TLR signaling (TLR1, TLR2), complement pathway (C3AR1, C1QA and C2), TYROBP signaling (TREM2, TYROBP), and cytoskeletal organization (AIF1, CAPG and WAS) (Figure 3C)(Hong et al., 2016; Marinelli et al., 2015; Yeh, Hansen, & Sheng, 2017)....

    [...]

Related Papers (5)
A core transcriptional signature of human microglia: Derivation and utility in describing region‐dependent alterations associated with Alzheimer's disease

[...]

01 Jul 2019-Glia
Anirudh Patir, Barbara Shih, Barry W. McColl, Tom C. Freeman 
A single cell-based atlas of human microglial states reveals associations with neurological disorders and histopathological features of the aging brain

[...]

11 Jun 2018-bioRxiv
Marta Olah, Menon, Naomi Habib, Mariko Taga, Christina J. Yung, Maria Cimpean, Khairalla A, Danielle Dionne, Sarah C. Hopp, Matthew P. Frosch, B. T. Hyman, Thomas G. Beach, Rani A. Sarkis, Garth Rees Cosgrove, Jeffrey Helgager, Jeffrey A. Golden, Page B. Pennell, Julie A. Schneider, David A. Bennett, Aviv Regev, Wassim Elyaman, Elizabeth M. Bradshaw, De Jager Pl 
Brain region-specific gene expression profiles in freshly isolated rat microglia

[...]

12 Mar 2015-Frontiers in Cellular Neuroscience
Karlijn J. Doorn, Karlijn J. Doorn, John J. P. Brevé, Benjamin Drukarch, Hendrikus Boddeke, Inge Huitinga, Paul J. Lucassen, Anne-Marie van Dam 
Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease

[...]

01 Feb 2016-Glia
Paul D. Wes, Inge R. Holtman, Erik Boddeke, Thomas Möller, Bart J. L. Eggen 
A map of transcriptional heterogeneity and regulatory variation in human microglia

[...]

20 Dec 2019-bioRxiv
Adam Mh Young, Natsuhiko Kumasaka, Fiona Calvert, Timothy R. Hammond, Andrew J Knights, Nikolaos Panousis, Jeremy Schwartzentruber, Jimmy Z. Liu, Kousik Kundu, Michael Segel, Natalia A. Murphy, Christopher E McMurran, Harry Bulstrode, Jason Correia, Karol P. Budohoski, Alexis J Joannides, Mathew R. Guilfoyle, Rikin A. Trivedi, Ramez W. Kirollos, Robert H. Morris, Matthew R. Garnett, Helen M Fernandes, Ivan Timofeev, Ibrahim Jalloh, Katherine Holland, Richard Mannion, Richard Mair, Colin Watts, Stephen J. Price, Peter J. Kirkpatrick, Thomas Santarius, Nicole Soranzo, Beth Stevens, Peter J. Hutchinson, Robin J.M. Franklin, Daniel J. Gaffney 
Frequently Asked Questions (1)
Q1. What are the contributions mentioned in the paper "A core transcriptional signature of human microglia: derivation" ?

The authors believe this resource and the analyses 49 described here, will support further investigations in the contribution of human 50 microglia towards the CNS in health and disease.